OmniAb Results Presentation Deck

Active Programs OUR PARTNERS CONTINUE TO START NEW PROGRAMS Number of Active Programs 300 250 200 150 100 50 0 2016 2017 2018 2019 2020 2021 2022 3/31/2023 • Number of active programs reached 301 (net of attrition) - Active Programs: -25% CAGR 2016 through 2022 Clinical and pre-clinical matriculation of programs continues, and new discovery-stage programs added Phase 1: 20 Preclinical: 14 301 Active Programs as of 03/31/2023 Phase 2: 2 Represents programs for which research work has commenced or an antigen is introduced into our animals and remains so as long as the program is actively being developed or commercialized Phase 3: 2 Approved: 3 6 Discovery: 260 OmniAb

View entire presentation